The available data of 338 cases of splenectomy in agnogenic myeloid metaplasia published since 1940 were retrieved from the literature and analysed. Postoperative survival was significantly shorter in patients with anaemia, massive splenomegaly or elevated serum alkaline phosphatase. Younger age or normal platelet counts were associated with a longer postoperative survival than that in older patients and in patients with low platelet counts respectively. The shortest median postoperative survival was found in: patients in whom serum alkaline phosphatase exceeded twice the upper limit of the normal; patients with anaemia (less than 10 g/dl haemoglobin) and massive splenomegaly (above 3 kg); and patients with anaemia and a splenic weight less than one kg.
Introduction
Advanced agnogenic myeloid metaplasia (AMM) is characterized by massive splenomegaly, which produces pain, pressure symptoms and contributes to the development of anaemia, thrombopenia and portal hypertension. Splenectomy has been repeatedly reported as relieving these manifestations (Mulder, Steenbergen and Haanen, 1977; Silverstein and ReMine, 1979) . The operation carries a relatively high mortality rate and is therefore recommended only for selected cases of AMM in whom the benefits of splenectomy appear to outweigh its risk (Silverstein, 1975; Silverstein and ReMine, 1979; Ward and Block, 1971) .
The accepted indications for splenectomy in AMM are painful splenomegaly, portal hypertension, refractory anaemia and thrombopenia (Silverstein and ReMine, 1979) . The operation is regarded as contra-indicated in patients with disseminated intravascular coagulation (Silverstein and ReMine, 1979) and thrombocythaemia (Ward and Block, 1971) . A shorter postoperative survival of male patients has been reported (Silverstein and ReMine, 1974) but not confirmed (Benbassat and Penchas, 1980) . The difficulty in selecting patients with AMM for splenectomy is compounded by the finding that the indications for splenectomy are of themselves also manifestations of advanced AMM and consequently predict poor survival (Benbassat, Penchas and Ligumski, 1979) .
The authors have recently surveyed the literature on splenectomy in AMM and reported a preliminary analysis of the prognostic significance of several clinical and laboratory variables at splenectomy (Benbassat et al., 1979) . In this paper a further evaluation is presented of the patients' age, haemoglobin level, platelet count, splenic size, serum alkaline phosphatase and combinations thereof as predictors of postoperative survival.
Methods
Reports on splenectomy in AMM published between January 1940 and December 1978 were retrieved from the medical literature as detailed previously. Altogether, 79 articles reporting a total of 332 cases were collected, and to these were added 6 cases from the records of the Hadassah University Hospital in Jerusalem. When available, clinical, laboratory and follow-up data were compiled for each individual case according to a predesignated format, and a digital computer was used for the analysis of the data. Breakdown of postoperative survival by date of publication showed that postoperative survival has not changed significantly during the last four decades (Benbassat et al., 1979) .
Survival functions were processed by the biomedical computer programs, P-series of the University of California Press, 1979 (Breslow, 1975; Mantel, 1966; Peto et al., 1977 *'High' alkaline phosphatase refers to concentrations above twice the upper limit of the normal. **n.s.=not significant (P>0-06).
phosphatase had a relatively long median survival even with splenic weight above 3 kg (Table 2) . Splenic weights of less than one kg were associated with a shorter median survival than that of patients with spleen weighing between one and 3 kg (Fig. 1) . The survival curve of patients with spleens of less than one kg depicted a heterogeneous population consisting of short-and long-lived groups of patients. Further breakdown of this survival curve by haemoglobin level suggested that its short-lived component consisted of patients with less than 10 g/dl haemoglobin at splenectomy (Table 3) .
Discussion
This survey identified two groups of patients with AMM who after splenectomy had a significantly shorter median survival than that of the remaining cases, and who should be considered as poor candidates for surgical treatment. The first group consisted of patients with very advanced AMM as judged by high concentrations of serum alkaline phosphatase. or splenic weights above 3 kg with less than 10 g/dl haemoglobin. Patients in whom the concentration of serum alkaline phosphatase exceeded twice the upper limit of the normal had a median postoperative survival of 9 months, and their prognosis was even poorer in the presence of a splenic weight of 3 kg or more. Patients with massive splenomegaly (more than 3 kg) and anaemia had a median survival of 7-4 months only. The second group of poor risk patients had at splenectomy a splenic weight of less than one kg, but also anaemia of less than 10 g/dl haemoglobin. Their median postoperative survival was 8-4 months and their postoperative mortality was 40% within the first three months. These patients may have belonged (Lubin, Rozen & Rywlin, 1976) . The validity of the present observations is limited by their retrospective nature. However, the data used, although imperfect, are the best available at present. In the absence of prospective studies several tentative conclusions may be drawn. It is suggested, that in addition to thrombocythaemia (Ward and Block, 1971 ) and disseminated intravascular coagulation (Silverstein. 1975 ) the following manifestations should be regarded as relative contra-indications for splenectomy in AMM: high concentrations of serum alkaline phosphatase; anaemia in the presence of an estimated splenic weight of 3 kg or more; and anaemia with an estimated splenic weight of one kg or less.
